Horizon Kinetics Medical ETF (NASDAQ:MEDX) Short Interest Update

Horizon Kinetics Medical ETF (NASDAQ:MEDX) was the target of a significant increase in short interest in February. As of February 27th, there was short interest totaling 2,418 shares, an increase of 255.6% from the February 12th total of 680 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average trading volume of 1,161 shares, the short-interest ratio is currently 2.1 days. Based on an average trading volume of 1,161 shares, the short-interest ratio is currently 2.1 days. Approximately 0.4% of the company’s stock are short sold.

Horizon Kinetics Medical ETF Stock Performance

Shares of NASDAQ MEDX traded up $0.12 during midday trading on Friday, hitting $33.54. 1,504 shares of the stock traded hands, compared to its average volume of 2,393. Horizon Kinetics Medical ETF has a one year low of $23.46 and a one year high of $35.46. The business has a 50 day moving average price of $34.09 and a two-hundred day moving average price of $32.45. The company has a market cap of $19.12 million, a PE ratio of 19.02 and a beta of 0.62.

Horizon Kinetics Medical ETF Announces Dividend

The firm also recently disclosed an annual dividend, which was paid on Wednesday, December 24th. Shareholders of record on Tuesday, December 23rd were issued a dividend of $0.4088 per share. The ex-dividend date was Tuesday, December 23rd. This represents a yield of 122.0%.

Horizon Kinetics Medical ETF Company Profile

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.